Design & Development News
-
Jarvik Launches Clinical Trial For Miniaturized Cardiovascular Implant
10/26/2016
The FDA has approved an investigational device exemption (IDE) clinical trial to investigate a left ventricular assist device (LVAD) system small enough for use in infants and children. The Jarvik 15mm device, introduced earlier this year by Jarvik Heart, is adjustable for long-term use in children as they grow and wait for a suitable heart transplant.
-
Stretchy Optical Fibers Could Detect Disease
10/24/2016
Optical fibers designed using biocompatible hydrogel could play a role in next-generation, flexible biosensors, according to scientists at Harvard University and MIT. By tracking the quality of light shining through the stretchy fibers, researchers could use the technology in implantable or wearable devices to monitor muscle mobility, tumor growth, or inflammation over time.
-
Mindray Introduces Updated, Touch-Enabled Ultrasound For Anesthesia Applications
10/22/2016
In conjunction with the American Society of Anesthesiologists (ASA) meeting in Chicago opening today, Mindray announces the introduction of its new L20-5s ultra high frequency linear transducer with enhanced iNeedle™ visualization technology.
-
3D-Printed Biodegradable Stents Bypass Traditional Stent Complications
10/21/2016
According to researchers, the citrus-based polymer material used has natural antioxidant properties, and could potentially be loaded with anti-coagulation drugs to minimize complications.
-
JDRF Grant Supports U. Of Toronto Research Into Hypoglycemia Prevention Patch
10/20/2016
JDRF and the University of Toronto are pleased to announce a $400,000 (USD) research grant to support the development of a skin [transdermal] patch to prevent hypoglycemia - a common, potentially life-threatening, risk for people living with type 1 diabetes (T1D).
-
Bigfoot Biomedical Raises $36M Toward Its “Artificial Pancreas” Development
10/19/2016
Bigfoot Biomedical, Inc., a highly anticipated precision medicine company founded by people directly impacted by Type 1 Diabetes (T1D), recently announced a Series A investment of $35.5 million, led by entities advised by Quadrant Capital Advisors, with participation from Cormorant Asset Management, Senvest Capital, and Visionnaire Ventures.
-
AdvaMed Loos To Foster Early-Stage Innovation
10/17/2016
The Advanced Medical Technology Association (AdvaMed) recently affirmed its commitment to advancing a comprehensive set of policy objectives to invigorate the innovation ecosystem for early-stage device and diagnostics companies.
-
UVA Scientists Combine MRI, Gamma Rays For HQ Medical Diagnostics
10/14/2016
A new medical imaging modality developed by scientists at the University of Virginia (UVA) combines magnetic resonance imaging (MRI) with gamma-ray imaging using xenon isotopes.
-
Verily, 3M Ink Pact To Develop Population Health Technology
10/13/2016
Verily Life Sciences (formerly Google Life Sciences) and 3M Health Information Systems are collaborating to develop population health technology focusing on clinical and financial tools to help hospitals and providers reduce costs and improve the quality of care. The two companies plan to build a joint platform that will measure rates of complications, readmissions, and mortality, lengths of stay, and line costs.
-
Abbott Collaborates With Drug Makers To Develop Genomic Test For Leukemia
10/13/2016
Abbott has entered into strategic collaborations with two pharmaceutical companies — Celgene and Agios — to develop diagnostic tests on Abbott’s m2000 RealTime system that identify certain genomic mutations associated with acute myeloid leukemia (AML). Both Celgene and Agios are currently developing experimental drugs that may halt the progression of AML by targeting these mutations.